New device aims to seal pancreas during robotic surgery, cutting leak risk

NCT ID NCT07687901

Not yet recruiting Disease control Sponsor: Hospital del Mar Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This pilot study tests a new device that uses radiofrequency energy to seal the pancreas during robotic surgery to remove the tail of the pancreas. The device, called Attachable Coolingbis®, is designed to reduce the common complication of pancreatic fluid leaks. Twenty adults with pancreatic tumors will undergo the procedure at four Spanish hospitals, and researchers will monitor safety and complication rates for up to one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Internally-cooled bipolar radiofrequency device (Attachable Coolingbis®)
What this could lead to: If successful, this device could reduce the high rate of pancreatic leaks after distal pancreatectomy, making robotic surgery safer for patients with pancreatic tumors.
What could go wrong: This is a small, early-stage pilot study with only 20 participants and no comparison group. The device may not reduce complications as hoped, and risks include bleeding, infection, or fistula formation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATECTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATECTOMY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.